HCMA HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION RECOGNIZED CENTER OF EXCELLENCE Trademark

Promoting public awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Promoting public interest and awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Charitable services, namely, promoting public awareness of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Arranging and conducting of volunteer programs and community service projects for charitable purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis

Printed educational course materials in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazine columns about hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed general feature magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed materials, namely, journals featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed journals in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed informational flyers featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed diagrams for hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis

Educational services, namely, conducting on line and telephonic instruction and courses in the field Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Educational services, namely, providing educational speakers in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Educational services, namely, providing online, video, and in-person classes, conducting lectures, seminars, and workshops in the fields of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Organizing, arranging, and conducting hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis educational events; Providing a website featuring non-downloadable videos in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Providing a website featuring non-downloadable audio recordings in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Educational services, namely, conducting programs in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Educational services, namely, providing on-line video, and in-person classes, conducting lectures, seminars, and workshops in the fields of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis

Providing an interactive website featuring technology that allows users to access educational services provided by webbasedapplications featuring non-downloadable videos featuring information onhypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Developing quality control standards for the multi-disciplinary care of hypertrophic cardiomyopathy related to the recognition of centers of excellence in hypertrophic cardiomyopathy care